Literature DB >> 9671466

Regulation of cellular genes in a chromosomal context by the retinoblastoma tumor suppressor protein.

A M Buchmann1, S Swaminathan, B Thimmapaya.   

Abstract

The retinoblastoma tumor suppressor gene product (pRb) is involved in controlling cell cycle progression from G1 into S. pRb functions, in part, by regulating the activities of several transcription factors, making pRb involved in the transcriptional control of cellular genes. Transient-transfection assays have implicated pRb in the transcription of several genes, including c-fos, the interleukin-6 gene, c-myc, cdc-2, c-neu, and the transforming growth factor beta2 gene. However, these assays place the promoter in an artificial context and exclude the effects of far 5' upstream regions and chromosomal architecture on gene transcription. In these experiments, we have studied the role of pRb in the control of cell cycle-related genes within a chromosomal context and within the context of the G1 phase of the cell cycle. We have used adenovirus vectors to overexpress pRb in human osteosarcoma cells and breast cells synchronized in early G1. By RNase protection assays, we have assayed the effects of this virus-produced pRb on gene expression in these cells. These results indicate that pRb is involved in the transcriptional downregulation of the E2F-1, E2F-2, dihydrofolate reductase, thymidine kinase, c-myc, proliferating-cell nuclear antigen, p107, and p21/Cip1 genes. However, it has no effect on the transcription of the E2F-3, E2F-4, E2F-5, DP-1, DP-2, or p16/Ink4 genes. The results are consistent with the notion that pRb controls the transcription of genes involved in S-phase promotion. They also suggest that pRb negatively regulates the transcription of two of the transcription factors whose activity it also represses, E2F-1 and E2F-2, and that it plays a role in downregulating the immediate-early gene response to serum stimulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9671466      PMCID: PMC109042          DOI: 10.1128/MCB.18.8.4565

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  63 in total

1.  Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family of proteins.

Authors:  B E Strober; J L Dunaief; S P Goff
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

2.  Transcriptional repression and growth suppression by the p107 pocket protein.

Authors:  P Starostik; K N Chow; D C Dean
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

Review 3.  Targeting chromatin disruption: Transcription regulators that acetylate histones.

Authors:  A P Wolffe; D Pruss
Journal:  Cell       Date:  1996-03-22       Impact factor: 41.582

Review 4.  Contributions of nuclear architecture to transcriptional control.

Authors:  G S Stein; A J van Wijnen; J Stein; J B Lian; M Montecino
Journal:  Int Rev Cytol       Date:  1995

5.  Mechanism of active transcriptional repression by the retinoblastoma protein.

Authors:  S J Weintraub; K N Chow; R X Luo; S H Zhang; S He; D C Dean
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

6.  The retinoblastoma protein modulates expression of genes coding for diverse classes of proteins including components of the extracellular matrix.

Authors:  M Rohde; P Warthoe; T Gjetting; J Lukas; J Bartek; M Strauss
Journal:  Oncogene       Date:  1996-06-06       Impact factor: 9.867

7.  A direct role of transcription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL60 cells.

Authors:  S Ishida; K Shudo; S Takada; K Koike
Journal:  Cell Growth Differ       Date:  1995-03

8.  Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.

Authors:  S N Khleif; J DeGregori; C L Yee; G A Otterson; F J Kaye; J R Nevins; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

9.  Transactivation of adenovirus E2-early promoter by E1A and E4 6/7 in the context of viral chromosome.

Authors:  S Swaminathan; B Thimmapaya
Journal:  J Mol Biol       Date:  1996-05-24       Impact factor: 5.469

10.  Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter.

Authors:  M B Datto; Y Yu; X F Wang
Journal:  J Biol Chem       Date:  1995-12-01       Impact factor: 5.157

View more
  6 in total

1.  Antisense-mediated depletion of p300 in human cells leads to premature G1 exit and up-regulation of c-MYC.

Authors:  S Kolli; A M Buchmann; J Williams; S Weitzman; B Thimmapaya
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

2.  Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.

Authors:  F A Dick; E Sailhamer; N J Dyson
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

3.  Repression of c-Myc and inhibition of G1 exit in cells conditionally overexpressing p300 that is not dependent on its histone acetyltransferase activity.

Authors:  Sudhakar Baluchamy; Hasan N Rajabi; Rama Thimmapaya; Arunasalam Navaraj; Bayar Thimmapaya
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

4.  Cooperation of E2F-p130 and Sp1-pRb complexes in repression of the Chinese hamster dhfr gene.

Authors:  Y C Chang; S Illenye; N H Heintz
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

5.  Molecular characterization of apoptosis induced by CARF silencing in human cancer cells.

Authors:  C T Cheung; R Singh; A R Yoon; M K Hasan; T Yaguchi; S C Kaul; C O Yun; R Wadhwa
Journal:  Cell Death Differ       Date:  2010-11-05       Impact factor: 15.828

6.  Next-generation sequencing of colorectal cancers in chinese: identification of a recurrent frame-shift and gain-of-function Indel mutation in the TFDP1 gene.

Authors:  Chen Chen; Jie Liu; Fan Zhou; Jianbo Sun; Lisha Li; Chengmeng Jin; Jiaofang Shao; Huawei Jiang; Na Zhao; Shu Zheng; Biaoyang Lin
Journal:  OMICS       Date:  2014-08-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.